Introduction
The T-cell receptor (TCR&CD3 complex is critical to T-cell recognition because it confers antigen-specificity and initiates a cascade of biochemical events that are essential to T-cell activation (see [l] for a review). Binding and aggregation of TCR-CD3 by MHC and antigenic peptide or by CD3 monoclonal antibody (mAb) is, in most model systems, insufficient to activate resting T cells, and may even induce tolerance (see [2] for a review). Multiple T-cell surface molecules have been demonstrated to be capable of co-stimulation that is sufficient to fully activate T cells, in combination with a TCR--CD3-mediated signal. Epically, this co-stimulation is demonstrated using experimental systems in which the presence of mAbs specific for these molecules facilitates activation of T cells by anti-TCR-CD3 mAbs or by specific antigen.
Since Clark reviewed data on four such molecules in 1986 [3] , the number of co-stimulatory or accessory molecules has mushroomed to more than 20 (for a review see [4] >. The excitement regarding n&b-mediated co-stimulation results from the presumption (which we share) that the mAbs often mimic the natural &and (delined here as the molecule expressed on an apposing cell that interacts with the T-cell accessory molecule). The next step is obligatory, and is the definition of the relevant ligands and analysis of their capacity to mediate co-stimulation (the best dehed are summarized in Fig. 1 ). I&and characterization has been achieved for three receptor-l&and pathways that participate in T-cell antigen-presenting cell @PC) interaction: CD2-lymphocyte fimction-associated antigen (LFA)3, LFA-l-intercellular adhesion molecule (IcAM)-1 and CD28-B7. We will review the progress that has been made in understanding these pathways. Comment is also made on parallels between these pathways and recently-defined adhesion pathways that mediate T-cell interaction with extracellular matrix (ECM): very late antigen (VIAPi-fibronectin (FN), VLA-5-FN, VLA-G-laminin (LN), VI.A+coUagen, CD26-collagen) (see Fig. 1 ).
Superl?cially, there appears to be a great redundancy of molecules involved in co-stimulation. On reflection, however, it becomes apparent that T-cell interactions with APCs are complex multistep processes that critically depend on both adhesion and signal transduction. As an illustration of this complex dialogue, we will also review in detail, the interaction of T cells with two kinds of APC, monocytes and B cells, with a particular emphasis on the roles of the T-cell molecules CD2, LFA-1 and CD28 in each case, we find that multiple signals are integrated by the participating cells and are used to program the differentiation events that result from the T-cell-APC encounter,
Interplay between adhesion and activation

Many adhesion molecules are involved in T-cell co-stimulation
Adhesion molecules are ideally situated to transduce information to the cell during the adhesion event i.e. to inform the cell that contact has been made and to convey information regarding the character of the apposing cell. This realization, obvious only in retrospect, emerges from the finding that many adhesion molecules also mediate co-stimulation. Thus adhesion molecules are not simply 'glue', but rather transducers of information.
CD2 was the first T-cell molecule for which dual roles in adhesion and activation were clearly established (for review see [5] ). Recent studies have relined these concepts. Because of the dramatic capacity of CD2 to ac-tivate cells, the importance of its adhesive role is often under emphasized. However, recent studies suggest that CD2-LFA-3 adhesion mediates substantial augmentation of antigen-specific T-cell responses [6*]: speciiitally, augmentation is observed following transfection of T cells with recombinant CD2 cDNA lacking the cytoplas mic domain responsible for the signalling capacity of the molecule. There is controversy over whether the functional synergism between CD2 and CD3 is partly a result of a physical association between the molecules: whereas one study provided evidence of physical association between CD2 and CD3 by co-precipitation analysis [7*], another failed to see co-clustering of CD3 with CD2 in the area of cell-cell interaction, during the antigen-independent phase of conjugation [@I.
In contrast to CD2, LFA-1 historically has been recognized principally as an adhesion molecule (for review see [9] >. LFA-1 mediates binding not only to activationinducible ligand RAM-1 but also to an additional ligand ICAM-[lo*], which is constitutively expressed on endothelial cells. Recent studies with ICAM-tmnsfectants [ 11*,12*] or with purikd ICAM-[ 13*,14*] indicate that the LFA-I-ICAMl pathway is also involved in co-stimulation of TCR-CD3mediated T-cell activation. Although the mechanism of co-stimulation remains unclear, evidence for signalling through LFA-1 comes from studies in which crosslinking of T cell LFA-1 with n-&s was found to induce increased intracellular Ca2+ [Ca2+ ]I concentrations [ I5*,16*].
The CD28 molecule was initially identiiied as a potent costimulator of T-cell activation (for a review see [ 171) . Re- cently, the CD28 ligand was identikl as the previously defined B-cell activation antigen B7 (or BB-1) [ 18**]. A dual role for the CD28B7 pathway in adhesion and costimulation has been demonstrated by the demonstration that immobilized purified B7 protein mediates T-cell adhesion and co-stimulation that results in T-cell proliferation and cytokine production [ 19*]. Studies of costimulation by mAb-ligation of CD28 have identified sev eral mechanisms by which CD28 influence T-cell activation. Firstly, aggregation of CD28 appears to activate a phospholipase C that is functionally different from that activatted by TCR-CD3 [20*]. Secondly, there is a unique transcriptional regulatory sequence in the interleukin (IL)-2 gene that is involved in CD28-induced activation [21*], and thirdly, CD28 co-stimulation partly acts by stabilization of cytokine mRNA (e.g. IL-21 [22*].
The concept of co-stimulation has been expanded by studies of ligands that are neither cytokines nor cell-surface molecules, but are ECM proteins. Co-stimulation by five such receptor-ECM interactions has been described. Four of the T-cell adhesion receptors for these ligands are members of the VA or j!ll (CD291 subfamily of integrins (for a review see [23] ). The details are complex because some of these receptors have more than one l&and, and one ligand may have various receptors. For example, T-cell MA-4 and VLA-5 bind to distinct sites on the ECM protein, FN [24., 25*] . The two other Tcell in&grin-mediated interactions implicated in co-stimulation are VU-3 binding to collagen [26*] and ~~4-6 binding to LN [25*] . Collagen also mediates co-stimula tion via the CD26 molecule (or Tp103, DPPIV) [26*], which is not a member of the in&grin family but is a dipeptidylpeptidase. All these receptor-l&and combinations co-stimulate in CD3 mAb-mediated T-cell activation [26*-30*].
The biological relevance of co-stimulation by ECM molecules remains to be defined. One interesting possibility is that the ECM environment that surrounds a T cell migrating through tissue, influences its ability to be activated, or its subsequent differentiation (see below). The strong parallels between T-cell interaction with ECM and with other cells is emphasized by the finding that VLA-4 is not only an FN receptor but also binds the cell-surface molecule VCAM-1 [31*]. The mode by which these ECM receptors co-stimulate is largely unknown although it has recently been shown that VLA5-media&l co-stimulation by FN induces the IL2 gene transcription factor AP-1 [32*].
Adhesion is acutely regulated by activation
T-cell adhesion is closely interconnected with T-cell activation. Not only does adhesion inlluence T-cell stimulation as mentioned above, but the activation state of the T cell also affects adhesion. The first detailed description of this active interplay between TCR-CD3-mediated activation and adhesion was given by Dustin and Springer [33**] for LFA-1 binding to ICAM-1. Subsequently TCR-CD3-mediated activation was also found to affect binding via the related integrins VIA-4, VIA5 and VLA-6 [25*], and a fifth molecule with a different structure, the CD8 glycoprotein [3&l. This contrasts with CD2-mediated adhesion, which appears to be lndependent of acute activation [35*]. For each of the four integrlns, TCR-CD3 crosslinking results in a rapid ( < 10 mln) increase in avid&y of adhesion without an increase in cell-surface expression of the particular receptors; furthermore, the augmentation of adhesion is transient. Although these results were obtained in artificial systems, they make a great deal of sense in their prediction that antigen-specllic T-cell recognition results in augmented adhesion that stabilizes the T-cell interactions with apposing cells (or ECM) for a perlod of time. The molecular mechanism(s) that accounts for these changes is not understood and may be regulated in part, by signals from the T-cell receptor via protein klnase C (PKC) because they are inhibited by the PKC inhibitor staurosporine ( [33**], and Y Shin&u unpublished data). Among many possibilities, two are particularly attractive explanations for the regulation of avidity. One is that intracellular events a&cting the integrin molecule (such as phosphotylation) induce conformational changes of the ligand-binding domain that alter its alllnity for ligand. The other is that intracellular events result in micro-clustering (either by self association or by cytoskeletal linkage), which augments local avidity [36] .
Activation via CD2 alone also appears to affect integrinmediated adhesion. Stimulating pairs of CD2 mAbs results in a rapid, increased avidity of LFA-1 and VLA integrins for their respective ligands [25',37'] 
A dialogue between T cells and APCS
h ~~gen-sp&fic interaction of a T cell with an APC can be regarded as a highly specific sequence of events, tich shows much resemblance to some of nature's complex 'mating rituals. Specific interaction between a T cell and an APC involves a bilateral exchange of signals, which triggers a biochemical cascade of events that lead to specific activation and differentiation not only of the T cell, but also of the apposing APC. Similarly, T-Bcell interactions may lead to activation and differentiation of B cells. Incomplete exchange of information may lead to a failure of complete activation, and may even induce the T cell to become anergic/tolerized to the improperly presented antigen.
T cell-monocyte interaction zany antigen-specific T-cell activation models use monocytes as APCs. Figure 2 collects information from various systems into a proposed sequence of signal exchanges that ultimately lead to T-cell proliferation and monocyte cytokine secretion by the monocyte. initial, weak cell con tact (Fig 2a) occurs between a T cell and monocyte; this initial contact may be mediated by LFA-1 (which has a low but detectable affinity for ICAM-1 on resting T cells) or by other receptor-l&and interactions. TCR-CD3 engagement by MHCantigen (Fig. 2b ) results in signal delivery in both the T cell and the monocyte. In the T cell, TCR-CD3 stimulation results in the induction of high avidity IFA-[33**], which considerably strengthens the T cell-monocyte interaction. Similarly, crosslinking of MHC-antigen on the monocyte induces high avidity LFA-1 on the monocyte [39']. This strengthened LFAl-dependent interaction may allow weaker adhesive interactions, such as CD2-LFA-3, to occur.
The ability of purified CD2 to induce IL-1 secretion from monocytes [49"] suggests that such interactions may be critically important in the induction of IL-1 mRNA Additional or alternative mechanisms for initial IL-1 mRNA production may also exist, as Landis et al. [50*] have reported that a cell contact-mediated signal provided by CD3 mAb-stimulated T cells (but not resting T cells) is important for the initial phase of IL-1 mRNA induction. This cell contact-mediated signal does not require new protein synthesis [ 50.1. Further activation of the monocyte leads to important cell-surface changes on the monocyte and ultimately to cytokine secretion (Fig. 2~) . Such activation may be mediated by cell contact-mediated signals of the T cell, and by soluble factors produced by the activated T cell [50*1 or other cells in the microenvironment.
Kaw&ami et al. [51**] have demonstrated in a monocytedependent model system that optimal T-cell activation requires crosslinking of the TCR-CD3 complex, the presence of the cytokines IL-lb and IL-~, and and IFN-y-induced membrane-bound co-stimulatoty signal expressed on monocytes. Studies of the molecules involved in this co-stimulation demonstrate a requirement for both the LFA-l-ICAM-and CD2-LFA-3 pathways, and increased ICAM-expression on the activated monocytes (GA van Seventer et al. unpublished data). This model system described by Kawakami et al.
[51**] shows much resemblance to the in vitro models for induction of clonal anergy in murine T helper (Th)l-type clones, In both, a cell contact-mediated signal, which cannot be replaced by the addition of various cytokines is required in addition to MHC and antigenic peptide, to elicit optimal T-cell stimulation, (see [2] for review). The exact nature of the membrane-bound co-stimulatoty signals in both systems is not well resolved. In our proposed model (Fig. 2) the expression of the membrane-bound co-stimulatory signal by the monocyte, along with induced secretion of cytokines such as IL-1 fl and IL-~ by the activated monocyte, finally leads to IL-a-dependent proliferation and differentiation of the T cell (Fig. 2d) .
T-cell-R-cell interaction
A similar dialogue occurs in T-B-cell interaction, although some of the molecules involved are different (see Fig. 3 ). Even though we have attempted to simplify the sequence of events for clarity, the T-B-cell interaction currently involves at least 14 different surface molecules on the two apposing cells! As with monocytes, weak adhesion (Fig. 3a) is followed by antigen-specific interaction of TCR-CD3 with antigen-MHC, and the delivery of signals to both the T cell and B cell (Fig. 3b) . Direct evidence for a role of the CD2-LFA-3 pathway (Fig 3b) is not yet established. Although not directly demonstrated, triggering of the antigen-MHC complex on the B cell may increase the adhesion of the B cell to the T cell; in addition, recent studies indicate that crosslinking of class II antigens on B cells results in the induced expression of the CD28 ligand B7/BB-1 [52*], which is likely to be critical in the later steps of this interaction (see below). On the T cell, TCR-CD3 activation results in high avidity LFA-1 function and increased T-cell adhesiveness [33**]. Studies of B-cell activation also suggest that a signal provided by CD3 mAb-activated T cells (but not resting T cells) is necessary for B-cell entry into the Gl phase of the cell cycle. This signal apparently requires synthesis of a new protein (Protein X in Fig. 3) [53**,54**,55*,5&]. Thus, (Fig. 3c) , denotes the delivery of a signal to the partially activated B cell by Protein X.
Step (Fig 3d) in volves B-cell co-stimulation of the T cell and is proposed as a result of evidence that activated, but not resting B cells are effective accessory cells for T-cell activation [ 571. Recent studies in murine models of in vitro induction of clonal anergy suggest that resting B cells lack the capability of highly enriched, activated B cells to provide the membrane-bound co-stimulatoty signal necessary to prevent induction of clonal anergy i58.1. The nature of any membrane-bound co-stimulatoty signal(s) on activated B cells remains largely undefined. Recently however, two studies have demonstrated that mAbs specific for CD28 or B7 inhibit allo-activation of CD4+ T cells by B lymphoblasts [ 52*,59*], which makes B7/'BB-1 a plausible candidate for such a membrane-bound co- Finally, B-cell co-stimulation of the T cell results in proliferation and dilfetentiation of the T cell. Initially T-cell secretion of IL-4 drives the B cell into the S phase of the cell cycle (Fig. 3e) [ 53**,54**,55*,56*]. Subsequently, the T cell produces IL-5, which induces IgM production and further isotype switching (Fig 3f) [55*,560]. T-cell-induced differentiation of B cells is also shown to be dependent on the LFA-l-ICAM- [@I, and CD28B7
[5$P] pathways. It is unclear, however, whether this solely reflects a role for these pathways in co-stimulation of T cells, leading to production of cytokines such as IL-4 and IL-5 by the T cell, or a more direct involvement of these pathways with differentiation of B cells. Thus this complex bidirectional interplay leads to proliferation and differentiation of both interacting cells.
Integration of multiple signals influences differentiation and effector function of T cells
It is an appealing concept that the multiplicity of molec ular Interactions between T cell and APC detetmine the specifics of activation, and subsequent differentiation of the T cell and APC. Support for this concept comes from evidence that various co-combinations of stimuli generated by dilferent accessory molecules induce tierent re sponses from T cells and different T-cell subsets respond diIferently to stimulation via accessory molecules. The former is of particular relevance to the present discussion Such regulation of alternative T-cell effector functions by co-stimulatory molecules is Illustrated by a recent study that describes IL-la production by T cells. Iate ( > 48 h) IL-la secretion is achieved by stimulation through combinations of CD2 and CD28 mAbs (or CD3 and CD28 mAbs), but not by any of these mAbs in isolation, although they are able to induce T-cell proliferation and TNF-a secretion [62*]. One can also envision that co-stimulatoty molecules may regulate different effector functions. For example, Eljaafari et al [63'] demonstrated that two distinct pairs of CD2 rnAbs (which possibly mimick different ligands), each of which induce dif ferent second messengers, stimulated bifunctional CD4+ T-cell clones to perform either helper or cytolytic functions. These data support the hypothesis that the combination of accessory-cell ligands expressed by an apposing APC will strongly shape the subsequent T-cell differentiation: ECM ligands in the vicinity may also contribute. 
Conclusion
Given the interest and progress in accessoty molecules, this review has barely scratched the surface. It has dealt with selected studies that illustrate the following themes, which we view as important in a general understanding of accessory molecules in T-cell activation. Firstly, there is a multiplicity of molecules involved in T-cell activation. Secondly, there is a dynamic interplay between adhesion and activation wherein adhesion molecules mediate signal transduction and intracellular signals modulate the character of the adhesion. Thirdly, cell-cell interactions such as T cell with APC involve a multistep dialogue be tween receptors on the T cell and their ligands on the APC. Finally multiple signals from these diverse molecular interactions are integrated by poorly defkd molecular processes within the cells, which then determine the specifks of activation and subsequent diiferentiation of the T cell and APC. Reports that atUnity-puriIied ICAMl provides co-stimulation in a CD3 mAi.-mediated proliferation model. Neither CDlla nor CD18 mAbs alone, induced a rise in [Caz+] , in T-cell clones, but combined with crosslInked CD3 mAbs a more prolonged calcium signal was observed than that observed when CD3 alone was ctossiinked. The IL-2 production and DNA synthesis were ~ greati enhanced under these conditions of crosslinking both CD3 and LFA-1. 
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